$43.63 +0.02 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  2. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus | Oct. 17, 2014 | 17:31PM EST
  3. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  4. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD | Oct. 9, 2014 | 14:38PM EST
  5. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  6. Action Heats Up in Ebola-Related Equities

    FoxBusiness | Oct. 1, 2014 | 09:15AM EST
  7. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus | Sep. 30, 2014 | 13:10PM EST
  8. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  9. Royal Bank of Scotland

    IBD | Sep. 25, 2014 | 18:53PM EST
  10. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  11. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  12. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  13. Widely Held Guru Stocks Trading In Europe

    GuruFocus | Sep. 22, 2014 | 17:56PM EST
  14. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  15. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus | Sep. 21, 2014 | 12:25PM EST
  16. China Fines Glaxo For Bribes

    IBD | Sep. 19, 2014 | 18:47PM EST
  17. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus | Sep. 16, 2014 | 12:27PM EST
  18. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD | Sep. 8, 2014 | 09:07AM EST
  19. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  20. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

    Benzinga | Aug. 26, 2014 | 15:56PM EST
  21. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD | Aug. 25, 2014 | 11:40AM EST
  22. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus | Aug. 21, 2014 | 16:01PM EST
  23. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

    Benzinga | Aug. 20, 2014 | 15:36PM EST
  24. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus | Aug. 18, 2014 | 11:54AM EST
  25. Intermune up on buyout buzz

    IBD | Aug. 13, 2014 | 18:58PM EST
  26. You Should Consider Adding GlaxoSmithKline Based on Tremendous ROE

    GuruFocus | Aug. 8, 2014 | 10:57AM EST
  27. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  28. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus | Aug. 5, 2014 | 10:51AM EST
  29. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  30. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga | Aug. 4, 2014 | 12:55PM EST
  31. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus | Aug. 4, 2014 | 11:12AM EST
  32. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga | Jul. 31, 2014 | 14:30PM EST
  33. A Look at the Week's Top Dividend Growers

    GuruFocus | Jul. 28, 2014 | 19:18PM EST
  34. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga | Jul. 28, 2014 | 16:36PM EST
  35. GlaxoSmithKline

    IBD | Jul. 24, 2014 | 18:57PM EST
  36. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD | Jul. 23, 2014 | 09:00AM EST
  37. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR Yo Apotex; Apotex Can No Longer Supply Authorized Generic Product

    Benzinga | Jul. 17, 2014 | 07:02AM EST
  38. Morning Market Movers

    Benzinga | Jul. 15, 2014 | 09:46AM EST
  39. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield

    Benzinga | Jul. 11, 2014 | 04:14AM EST
  40. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus | Jul. 1, 2014 | 17:05PM EST
  41. British Stocks: Sweet Spot For European Value

    YCharts | Jun. 26, 2014 | 19:02PM EST
  42. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus | Jun. 26, 2014 | 15:40PM EST
  43. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga | Jun. 19, 2014 | 10:27AM EST
  44. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks

    Benzinga | Jun. 18, 2014 | 09:38AM EST
  45. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD | Jun. 12, 2014 | 12:57PM EST
  46. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering Efficacy, Safety of Incruse(TM) Ellipta(R) Plus Relvar(R)/Breo(R) Ellipta(R) for COPD

    Benzinga | Jun. 11, 2014 | 07:44AM EST
  47. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus | Jun. 10, 2014 | 19:34PM EST
  48. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga | Jun. 4, 2014 | 13:58PM EST
  49. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy

    Benzinga | Jun. 4, 2014 | 10:32AM EST
  50. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga | May. 14, 2014 | 12:36PM EST
Trading Center